Global Olanzapine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Olanzapine market size will reach 230.55 Million USD in 2025 and is projected to reach 276.68 Million USD by 2032, with a CAGR of 2.64% (2025-2032). Notably, the China Olanzapine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Olanzapine is a medication that belongs to a class of drugs called atypical antipsychotics. It is primarily used in the treatment of various mental health conditions, including schizophrenia and bipolar disorder. Olanzapine works by balancing the levels of certain neurotransmitters in the brain, specifically dopamine and serotonin, which are involved in regulating mood, behavior, and cognition. By blocking the receptors for these neurotransmitters, olanzapine helps to reduce symptoms such as hallucinations, delusions, disorganized thinking, and mood swings. It is available in tablet or injection form and is usually taken once daily. Olanzapine may be used alone or in combination with other medications as part of a comprehensive treatment plan. Like all medications, olanzapine can have potential side effects, including drowsiness, weight gain, increased blood sugar levels, and changes in cholesterol levels. Therefore, it is important for individuals taking olanzapine to be monitored by a healthcare professional and to discuss any concerns or side effects experienced.
The major global manufacturers of Olanzapine include Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Mylan Pharmaceuticals, Apotex, Par Pharmaceutical, Torrent Pharmaceuticals, Aurobindo Pharma, Sandoz, Sun Pharmaceutical, Jubilant Lifesciences, Hansoh Pharmaceutical, Changzhou WATSON Pharmaceuticals, Zhejiang Langhua Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Olanzapine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Olanzapine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Olanzapine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Olanzapine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Olanzapine Include:
Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Mylan Pharmaceuticals
Apotex
Par Pharmaceutical
Torrent Pharmaceuticals
Aurobindo Pharma
Sandoz
Sun Pharmaceutical
Jubilant Lifesciences
Hansoh Pharmaceutical
Changzhou WATSON Pharmaceuticals
Zhejiang Langhua Pharmaceuticals
Olanzapine Product Segment Include:
5 mg Tablet
10 mg Tablet
Olanzapine Product Application Include:
Schizophrenia
Severe Mania
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Olanzapine Industry PESTEL Analysis
Chapter 3: Global Olanzapine Industry Porter's Five Forces Analysis
Chapter 4: Global Olanzapine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Olanzapine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Olanzapine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Olanzapine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Olanzapine market size will reach 230.55 Million USD in 2025 and is projected to reach 276.68 Million USD by 2032, with a CAGR of 2.64% (2025-2032). Notably, the China Olanzapine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Olanzapine is a medication that belongs to a class of drugs called atypical antipsychotics. It is primarily used in the treatment of various mental health conditions, including schizophrenia and bipolar disorder. Olanzapine works by balancing the levels of certain neurotransmitters in the brain, specifically dopamine and serotonin, which are involved in regulating mood, behavior, and cognition. By blocking the receptors for these neurotransmitters, olanzapine helps to reduce symptoms such as hallucinations, delusions, disorganized thinking, and mood swings. It is available in tablet or injection form and is usually taken once daily. Olanzapine may be used alone or in combination with other medications as part of a comprehensive treatment plan. Like all medications, olanzapine can have potential side effects, including drowsiness, weight gain, increased blood sugar levels, and changes in cholesterol levels. Therefore, it is important for individuals taking olanzapine to be monitored by a healthcare professional and to discuss any concerns or side effects experienced.
The major global manufacturers of Olanzapine include Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Mylan Pharmaceuticals, Apotex, Par Pharmaceutical, Torrent Pharmaceuticals, Aurobindo Pharma, Sandoz, Sun Pharmaceutical, Jubilant Lifesciences, Hansoh Pharmaceutical, Changzhou WATSON Pharmaceuticals, Zhejiang Langhua Pharmaceuticals, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Olanzapine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Olanzapine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Olanzapine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Olanzapine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Olanzapine Include:
Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Mylan Pharmaceuticals
Apotex
Par Pharmaceutical
Torrent Pharmaceuticals
Aurobindo Pharma
Sandoz
Sun Pharmaceutical
Jubilant Lifesciences
Hansoh Pharmaceutical
Changzhou WATSON Pharmaceuticals
Zhejiang Langhua Pharmaceuticals
Olanzapine Product Segment Include:
5 mg Tablet
10 mg Tablet
Olanzapine Product Application Include:
Schizophrenia
Severe Mania
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Olanzapine Industry PESTEL Analysis
Chapter 3: Global Olanzapine Industry Porter's Five Forces Analysis
Chapter 4: Global Olanzapine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Olanzapine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Olanzapine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Olanzapine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Olanzapine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Olanzapine Product by Type
- 1.2.1 5 mg Tablet
- 1.2.2 10 mg Tablet
- 1.3 Olanzapine Product by Application
- 1.3.1 Schizophrenia
- 1.3.2 Severe Mania
- 1.4 Global Olanzapine Market Revenue and Sales Analysis
- 1.4.1 Global Olanzapine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Olanzapine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Olanzapine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Olanzapine Market Development Status and Trends
- 1.5.1 Olanzapine Industry Development Status Analysis
- 1.5.2 Olanzapine Industry Development Trends Analysis
- 2 Olanzapine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Olanzapine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Olanzapine Market Analysis by Country
- 4.1 Global Olanzapine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Olanzapine Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Olanzapine Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Olanzapine Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Olanzapine Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Olanzapine Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Olanzapine Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Olanzapine Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Olanzapine Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Olanzapine Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Olanzapine Average Sales Price by Manufacturers (2021-2025)
- 5.2 Olanzapine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Olanzapine Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Olanzapine Market Analysis by Type
- 6.1 Global Olanzapine Market Revenue Analysis by Type
- 6.1.1 Global Olanzapine Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Olanzapine Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Olanzapine Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Olanzapine Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Lilly
- 7.1.1 Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Lilly Olanzapine Product Portfolio
- 7.1.3 Lilly Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Teva Pharmaceutical
- 7.2.1 Teva Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Teva Pharmaceutical Olanzapine Product Portfolio
- 7.2.3 Teva Pharmaceutical Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Dr. Reddy＇s Laboratories
- 7.3.1 Dr. Reddy＇s Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Dr. Reddy＇s Laboratories Olanzapine Product Portfolio
- 7.3.3 Dr. Reddy＇s Laboratories Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Mylan Pharmaceuticals
- 7.4.1 Mylan Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Mylan Pharmaceuticals Olanzapine Product Portfolio
- 7.4.3 Mylan Pharmaceuticals Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Apotex
- 7.5.1 Apotex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Apotex Olanzapine Product Portfolio
- 7.5.3 Apotex Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Par Pharmaceutical
- 7.6.1 Par Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Par Pharmaceutical Olanzapine Product Portfolio
- 7.6.3 Par Pharmaceutical Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Torrent Pharmaceuticals
- 7.7.1 Torrent Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Torrent Pharmaceuticals Olanzapine Product Portfolio
- 7.7.3 Torrent Pharmaceuticals Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Aurobindo Pharma
- 7.8.1 Aurobindo Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Aurobindo Pharma Olanzapine Product Portfolio
- 7.8.3 Aurobindo Pharma Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Sandoz
- 7.9.1 Sandoz Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Sandoz Olanzapine Product Portfolio
- 7.9.3 Sandoz Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Sun Pharmaceutical
- 7.10.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Sun Pharmaceutical Olanzapine Product Portfolio
- 7.10.3 Sun Pharmaceutical Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Jubilant Lifesciences
- 7.11.1 Jubilant Lifesciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Jubilant Lifesciences Olanzapine Product Portfolio
- 7.11.3 Jubilant Lifesciences Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 Hansoh Pharmaceutical
- 7.12.1 Hansoh Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Hansoh Pharmaceutical Olanzapine Product Portfolio
- 7.12.3 Hansoh Pharmaceutical Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 Changzhou WATSON Pharmaceuticals
- 7.13.1 Changzhou WATSON Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Changzhou WATSON Pharmaceuticals Olanzapine Product Portfolio
- 7.13.3 Changzhou WATSON Pharmaceuticals Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.14 Zhejiang Langhua Pharmaceuticals
- 7.14.1 Zhejiang Langhua Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Zhejiang Langhua Pharmaceuticals Olanzapine Product Portfolio
- 7.14.3 Zhejiang Langhua Pharmaceuticals Olanzapine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Olanzapine Industry Chain Analysis
- 8.2 Olanzapine Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Olanzapine Product Downstream Application Analysis
- 8.3.1 Global Olanzapine Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Olanzapine Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Olanzapine Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Olanzapine Typical Downstream Customers
- 8.5 Olanzapine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
